William T. Andrews - Jun 2, 2025 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Medical Officer
Signature
/s/ William T. Andrews
Stock symbol
CPRX
Transactions as of
Jun 2, 2025
Transactions value $
$0
Form type
3
Date filed
6/6/2025, 05:00 PM
Previous filing
Nov 19, 2021
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrews William T. Chief Medical Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ William T. Andrews 2025-06-06 0001638459

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CPRX Common Stock, par value $0.001 per share 0 Jun 2, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase common stock Jun 2, 2025 Common Stock 124K $24.90 Direct F1
holding CPRX Restricted Stock Units Jun 2, 2025 Common Stock 15.3K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative Securities vest in five annual tranches beginning on June 2, 2026.
F2 Shares of common stock will be delivered to the Reporting Person upon vesting.
F3 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.